BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 12, 2011
View Archived Issues
Biotie Beefs up CNS Pipe with $120M Synosia Buy
LONDON – Biotie Therapies Corp. is acquiring Synosia Therapeutics Holding AG in an all-share deal that values the private Swiss company at €93.6 million (US$120.95 million). (BioWorld International)
Read More
Symphogen Financing Largest for Private European Biotech
Read More
Immutep Lands $100M License for Autoimmune Drugs with GSK
Read More
Human Protein Can Turn on Immune Response to Cancer
Read More
Neurosearch Restructures, Preps to Market Huntexil
Read More
Cell Medica to Automate Cell Therapy for Commercialization
Read More
Spirogen, Genentech Ink Antibody Drug Conjugate Deal
Read More
Santaris and Pfizer Agree to $614M RNA Collaboration
Read More
Amarin Raises $91.2M in Public Offering for AMR101 Sales Prep
Read More
Other News To Note
Read More